Encompass Health Corp [EHC] stock is trading at $100.36, down -0.51%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EHC shares have gain 1.01% over the last week, with a monthly amount drifted -0.27%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Encompass Health Corp [NYSE: EHC] stock has seen the most recent analyst activity on October 11, 2024, when KeyBanc Capital Markets initiated its Overweight rating and assigned the stock a price target of $115. Previously, Leerink Partners started tracking the stock with Outperform rating on July 10, 2024, and set its price target to $100. On March 06, 2024, Barclays initiated with a Overweight rating and assigned a price target of $95 on the stock. Barclays started tracking the stock assigning a Equal Weight rating and suggested a price target of $57 on March 14, 2023. UBS initiated its recommendation with a Buy and recommended $98 as its price target on September 24, 2021. Raymond James upgraded its rating to Strong Buy for this stock on August 02, 2021, and upped its price target to $107. In a note dated November 23, 2020, Barclays upgraded an Overweight rating on this stock but restated the target price of $96.
Encompass Health Corp [EHC] stock has fluctuated between $76.11 and $104.55 over the past year. Currently, Wall Street analysts expect the stock to reach $97 within the next 12 months. Encompass Health Corp [NYSE: EHC] shares were valued at $100.36 at the most recent close of the market. An investor can expect a potential drop of -3.35% based on the average EHC price forecast.
Analyzing the EHC fundamentals
Encompass Health Corp [NYSE:EHC] reported sales of 5.37B for the trailing twelve months, which represents a growth of 12.69%. Gross Profit Margin for this corporation currently stands at 0.29% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.22 and Total Capital is 0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 99.68 points at the first support level, and at 99.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 101.50, and for the 2nd resistance point, it is at 102.64.
Ratios To Look Out For
For context, Encompass Health Corp’s Current Ratio is 1.05. As well, the Quick Ratio is 1.05, while the Cash Ratio is 0.1. Considering the valuation of this stock, the price to sales ratio is 1.88, the price to book ratio is 4.89 and price to earnings (TTM) ratio is 22.50.
Transactions by insiders
Recent insider trading involved Price Andrew L, Chief Accounting Officer, that happened on Feb 13 ’25 when 5042.0 shares were sold. EVP & Chief Financial Officer, COLTHARP DOUGLAS E completed a deal on Aug 13 ’24 to sell 12260.0 shares. Meanwhile, Officer Douglas Coltharp bought 12260.0 shares on Aug 13 ’24.
